Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients
- Eric Lawitz
- , Maribel Rodriguez-Torres
- , Andrew J. Muir
- , Tara L. Kieffer
- , Lindsay McNair
- , Ariya Khunvichai
- , John G. McHutchison
Research output: Contribution to journal › Article › peer-review
125
Link opens in a new tab
Scopus
citations